The Antitrust Review of the Americas 2016

US: Pharmaceutical Antitrust

The past year has arguably seen more US case law developments in the area of pharmaceutical antitrust than ever before. This chapter focuses on the four types of pharmaceutical antitrust cases that have been most active this year:

Interested in becoming a GCR author? Please contact our Insight Manager.

Get in touch